BRIAN HOLLER / THE ARCHIVE
cannabis-research
Reporting, observations, and practical ideas from business, cannabis, media, culture, and the places they meet.
100% of Cannabis Consumers Say QR Codes Make Them Feel More Protected
A cannabis QR-code study produced an unusually strong trust signal. The durable lesson is bigger than the technology: verified product information can reduce uncertainty when consumers understand who…
Topical CBD Cut Myofascial Pain 41% in a New Clinical Study
A controlled human study of topical CBD for myofascial pain reported a 41% reduction in pain, but the useful takeaway is precision: promising results should sharpen cannabis health…
Congress Wants the VA to Study the Cannabis Veterans Actually Use
Veterans already use cannabis while federal research and guidance remain incomplete. The better policy response is research built around real-world products and behavior without outrunning what the evidence…
A Minnesota Study Says Medical Cannabis Eased Anxiety and Depression in Autism Patients. Read the Fine Print.
Minnesota observational data from 1,800 medical-cannabis patients with autism found meaningful reported improvements in anxiety and other symptoms. Without a control group or standardized treatment, the findings are…
Congress Wants the VA to Finally Study Medical Marijuana for Veterans With PTSD and Chronic Pain
Congressional pressure for VA cannabis research reflects a persistent evidence gap around PTSD and chronic pain. Veteran access deserves rigorous study, transparent limitations and research designed around the…
Balanced THC and CBD Cut Endometriosis Pain in Berlin Pilot Study
A Berlin pilot study of balanced THC/CBD for endometriosis pain reported promising improvements, but the sample was small and the evidence remains preliminary. Formulation details and study design…
Where Medical Cannabis Can Still Deliver Returns: A 12 Market Reality Check for 2026
A 12-market medical-cannabis survey shows why international opportunity cannot be reduced to population or headline legalization. Access, protectionism, GMP requirements and regulatory consistency determine whether growth becomes investable.
FIND YOUR NEXT THREAD